Kailera Therapeutics Insider Acquires Additional 500,000 Shares for $8 Million
RTW Investments, a 10% owner of Kailera Therapeutics (KLRA), acquired 500,000 shares of common stock for $8 million at $16 per share on April 20, 2026. The transaction increased RTW's indirect holdings to 10,776,820 shares, while direct ownership remained at zero. The purchase price was below the closing market price of $24.61.
Topics: Kailera Therapeutics ownership structure RTW Investments SEC filing stock acquisition